Trade Cytori Therapeutics - PSTV CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.75 |
| Open | 1.73 |
| 1-Year Change | -21.36% |
| Day's Range | 1.71 - 1.89 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 1.76 | 0.01 | 0.57% | 1.75 | 1.76 | 1.68 |
| Jul 24, 2024 | 1.67 | -0.06 | -3.47% | 1.73 | 1.77 | 1.63 |
| Jul 23, 2024 | 1.70 | 0.00 | 0.00% | 1.70 | 1.76 | 1.67 |
| Jul 22, 2024 | 1.70 | -0.04 | -2.30% | 1.74 | 1.75 | 1.57 |
| Jul 19, 2024 | 1.72 | 0.02 | 1.18% | 1.70 | 1.84 | 1.68 |
| Jul 18, 2024 | 1.69 | -0.05 | -2.87% | 1.74 | 1.75 | 1.68 |
| Jul 17, 2024 | 1.74 | -0.10 | -5.43% | 1.84 | 2.01 | 1.69 |
| Jul 16, 2024 | 1.81 | 0.05 | 2.84% | 1.76 | 1.87 | 1.75 |
| Jul 15, 2024 | 1.75 | -0.03 | -1.69% | 1.78 | 1.86 | 1.70 |
| Jul 12, 2024 | 1.76 | -0.07 | -3.83% | 1.83 | 1.85 | 1.70 |
| Jul 11, 2024 | 1.79 | -0.02 | -1.10% | 1.81 | 1.84 | 1.72 |
| Jul 10, 2024 | 1.82 | 0.33 | 22.15% | 1.49 | 1.86 | 1.49 |
| Jul 9, 2024 | 1.47 | 0.05 | 3.52% | 1.42 | 1.48 | 1.38 |
| Jul 8, 2024 | 1.47 | -0.08 | -5.16% | 1.55 | 1.55 | 1.41 |
| Jul 5, 2024 | 1.50 | -0.01 | -0.66% | 1.51 | 1.51 | 1.48 |
| Jul 3, 2024 | 1.51 | 0.03 | 2.03% | 1.48 | 1.51 | 1.48 |
| Jul 2, 2024 | 1.49 | 0.01 | 0.68% | 1.48 | 1.50 | 1.48 |
| Jul 1, 2024 | 1.45 | 0.04 | 2.84% | 1.41 | 1.60 | 1.41 |
| Jun 28, 2024 | 1.42 | 0.00 | 0.00% | 1.42 | 1.47 | 1.38 |
| Jun 27, 2024 | 1.44 | -0.08 | -5.26% | 1.52 | 1.52 | 1.40 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cytori Therapeutics Company profile
About Plus Therapeutics Inc
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma. The Company also focuses on developing Rhenium-186 NanoLiposome (186RNL) for the treatment of recurrent glioblastoma-a rare, incurable and fatal disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Plus Therapeutics Inc revenues decreased from $303K to $0K. Net loss increased 63% to $13.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development increase of 97% to $5.2M (expense), Change in fair value of liability instru decrease of 100% to $6K (income).
Equity composition
Common Stock $.001 Par, 02/11, 95M auth., 51,963,679 issd. Insiders own 14.62% IPO:N/A. 05/16, 1-for-15 reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
4200 Marathon Blvd Ste 200
AUSTIN
TEXAS 78756-3433
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com